Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Pre-Tax Profit Margin 2011-2025 | BMY

Current and historical pre-tax profit margin for Bristol Myers Squibb (BMY) from 2011 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Bristol Myers Squibb pre-tax profit margin for the three months ending September 30, 2025 was .
Bristol Myers Squibb Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2025-09-30 $48.03B $8.03B 16.72%
2025-06-30 $47.70B $6.60B 13.82%
2025-03-31 $47.64B $6.11B 12.82%
2024-12-31 $48.30B $-8.38B -17.35%
2024-09-30 $47.44B $-6.88B -14.50%
2024-06-30 $46.51B $-6.42B -13.80%
2024-03-31 $45.53B $-5.85B -12.84%
2023-12-31 $45.01B $8.44B 18.75%
2023-09-30 $44.94B $8.63B 19.19%
2023-06-30 $45.19B $8.70B 19.25%
2023-03-31 $45.85B $8.80B 19.19%
2022-12-31 $46.16B $7.71B 16.71%
2022-09-30 $46.74B $7.71B 16.50%
2022-06-30 $47.14B $7.66B 16.25%
2022-03-31 $46.96B $7.26B 15.45%
2021-12-31 $46.39B $8.10B 17.46%
2021-09-30 $45.47B $-4.21B -9.26%
2021-06-30 $44.38B $-4.11B -9.26%
2021-03-31 $42.81B $-4.04B -9.43%
2020-12-31 $42.52B $-6.87B -16.16%
2020-09-30 $39.40B $3.45B 8.76%
2020-06-30 $34.86B $2.54B 7.29%
2020-03-31 $31.01B $2.69B 8.68%
2019-12-31 $26.15B $4.98B 19.03%
2019-09-30 $24.17B $6.61B 27.34%
2019-06-30 $23.86B $7.43B 31.13%
2019-03-31 $23.29B $6.17B 26.49%
2018-12-31 $22.56B $5.97B 26.45%
2018-09-30 $22.04B $5.16B 23.42%
2018-06-30 $21.60B $4.18B 19.34%
2018-03-31 $21.04B $4.96B 23.55%
2017-12-31 $20.78B $5.13B 24.70%
2017-09-30 $20.57B $5.52B 26.83%
2017-06-30 $20.24B $5.90B 29.13%
2017-03-31 $19.97B $6.22B 31.13%
2016-12-31 $19.43B $5.92B 30.45%
2016-09-30 $18.47B $4.42B 23.92%
2016-06-30 $17.62B $3.85B 21.84%
2016-03-31 $16.91B $2.28B 13.51%
2015-12-31 $16.56B $2.08B 12.54%
2015-09-30 $16.53B $2.43B 14.68%
2015-06-30 $16.38B $2.45B 14.94%
2015-03-31 $16.11B $2.84B 17.65%
2014-12-31 $15.88B $2.38B 14.99%
2014-09-30 $16.06B $3.31B 20.61%
2014-06-30 $16.21B $3.12B 19.25%
2014-03-31 $16.37B $3.20B 19.57%
2013-12-31 $16.39B $2.89B 17.64%
2013-09-30 $16.14B $2.54B 15.71%
2013-06-30 $15.81B $0.46B 2.90%
2013-03-31 $16.20B $0.99B 6.09%
2012-12-31 $17.62B $2.34B 13.28%
2012-09-30 $18.88B $3.42B 18.12%
2012-06-30 $20.49B $6.51B 31.77%
2012-03-31 $21.48B $7.24B 33.70%
2011-12-31 $21.24B $6.98B 32.86%
2011-09-30 $20.90B $6.80B 32.53%
2011-06-30 $20.35B $6.58B 32.35%
2011-03-31 $19.69B $6.39B 32.44%
2010-12-31 $19.48B $6.07B 31.16%
2010-09-30 $19.41B $5.98B 30.80%
2010-06-30 $19.40B $5.93B 30.57%
2010-03-31 $19.29B $5.86B 30.37%
2009-12-31 $18.81B $5.60B 29.79%
2009-09-30 $16.14B $5.48B 33.92%
2009-06-30 $16.61B $5.07B 30.50%
2009-03-31 $17.15B $4.76B 27.78%
2008-12-31 $17.72B $4.78B 26.96%
2008-09-30 $17.58B $3.01B 17.14%
2008-06-30 $16.92B $3.11B 18.40%
2008-03-31 $16.19B $2.88B 17.78%
2007-12-31 $15.62B $2.52B 16.16%
2007-09-30 $15.90B $2.26B 14.20%
2007-06-30 $15.45B $1.62B 10.48%
2007-03-31 $15.85B $1.74B 11.00%
2006-12-31 $16.21B $2.09B 12.86%
2006-09-30 $18.12B $3.54B 19.54%
2006-06-30 $18.73B $4.55B 24.29%
2006-03-31 $18.75B $4.57B 24.37%
2005-12-31 $18.61B $4.30B 23.13%
2005-09-30 $19.35B $4.72B 24.41%
2005-06-30 $19.36B $4.24B 21.92%
2005-03-31 $19.29B $3.88B 20.13%
2004-12-31 $19.38B $4.42B 22.80%
2004-09-30 $19.30B $4.30B 22.29%
2004-06-30 $19.89B $4.52B 22.71%
2004-03-31 $20.20B $5.00B 24.72%
2003-12-31 $20.31B $4.69B 23.12%
2003-09-30 $18.11B $4.45B 24.58%
2003-06-30 $17.28B $3.21B 18.56%
2003-03-31 $16.28B $2.68B 16.49%
2002-12-31 $16.21B $2.75B 16.95%
2002-09-30 $17.47B $-0.46B -2.64%
2002-06-30 $17.43B $1.03B 5.89%
2002-03-31 $18.02B $1.80B 10.01%
2001-12-31 $18.04B $2.26B 12.54%
2001-09-30 $19.40B $5.95B 30.68%
2001-06-30 $19.46B $5.49B 28.21%
2001-03-31 $19.17B $5.35B 27.91%
2000-12-31 $18.93B $5.19B 27.43%
2000-09-30 $18.84B $5.49B 29.12%
2000-06-30 $19.32B $5.86B 30.36%
2000-03-31 $19.82B $5.82B 29.37%
1999-12-31 $20.22B $5.77B 28.52%
1999-09-30 $19.70B $4.78B 24.26%
1999-06-30 $19.18B $4.61B 24.01%
1999-03-31 $18.69B $4.45B 23.82%
1998-12-31 $18.28B $4.27B 23.34%
1998-09-30 $17.84B $4.92B 27.60%
1998-06-30 $17.47B $4.77B 27.32%
1998-03-31 $17.10B $4.64B 27.14%
1997-12-31 $16.70B $4.48B 26.84%
1997-09-30 $16.22B $4.37B 26.94%
1997-06-30 $15.81B $4.23B 26.78%
1997-03-31 $15.44B $4.12B 26.71%
1996-12-31 $15.07B $4.01B 26.64%
1996-09-30 $14.72B $2.93B 19.91%
1996-06-30 $14.39B $2.83B 19.66%
1996-03-31 $14.14B $2.77B 19.58%
1995-12-31 $13.77B $2.40B 17.45%
1995-09-30 $13.41B $2.81B 20.92%
1995-06-30 $12.93B $2.72B 21.05%
1995-03-31 $12.45B $2.63B 21.13%
1994-12-31 $11.98B $2.56B 21.32%
1994-09-30 $11.73B $2.49B 21.26%
1994-06-30 $11.66B $2.44B 20.95%
1994-03-31 $11.49B $2.37B 20.66%
1993-12-31 $11.41B $2.57B 22.53%
1993-09-30 $11.24B $2.06B 18.36%
1993-06-30 $11.33B $2.05B 18.09%
1993-03-31 $11.41B $2.01B 17.66%
1992-12-31 $11.29B $1.99B 17.59%
1992-09-30 $10.82B $2.83B 26.15%
1992-06-30 $10.63B $2.81B 26.40%
1992-03-31 $10.48B $2.83B 27.02%
1991-12-31 $10.57B $2.78B 26.34%
1991-09-30 $10.40B $2.70B 25.95%
1991-06-30 $10.26B $2.63B 25.63%
1991-03-31 $10.02B $2.54B 25.37%
1990-12-31 $9.74B $2.43B 24.98%
1990-06-30 $6.53B $1.61B 24.62%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $95.049B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $262.317B 18.51
Amgen (AMGN) United States $172.422B 14.64
Gilead Sciences (GILD) United States $147.457B 14.51
Vertex Pharmaceuticals (VRTX) United States $103.890B 26.75
GSK (GSK) United Kingdom $94.678B 10.53
Regeneron Pharmaceuticals (REGN) United States $69.106B 17.93
Alnylam Pharmaceuticals (ALNY) United States $58.487B 1924.78
CSL (CSLLY) Australia $56.375B 0.00
Argenex SE (ARGX) Netherlands $52.620B 65.34
Insmed (INSM) United States $40.458B 0.00
Novozymes (NVZMY) Denmark $30.060B 0.00
BioNTech SE (BNTX) Germany $24.801B 0.00
Biogen (BIIB) United States $22.814B 9.29
Royalty Pharma (RPRX) United States $22.487B 8.53
Incyte (INCY) United States $20.806B 19.92
Genmab (GNMSF) Denmark $19.195B 14.08
Illumina (ILMN) United States $18.626B 27.96
Genmab (GMAB) Denmark $18.402B 13.85
Roivant Sciences (ROIV) United Kingdom $14.081B 0.00
Exact Sciences (EXAS) United States $12.539B 348.32
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Ascendis Pharma (ASND) Denmark $12.200B 0.00
Guardant Health (GH) United States $12.191B 0.00
Revolution Medicines (RVMD) United States $11.794B 0.00
Exelixis (EXEL) United States $10.942B 17.51
Avidity Biosciences (RNA) United States $10.190B 0.00
BioMarin Pharmaceutical (BMRN) United States $9.886B 17.93
QIAGEN (QGEN) Netherlands $9.683B 18.38
Moderna (MRNA) United States $9.587B 0.00
Bio-Techne Corp (TECH) United States $8.945B 33.38
Metsera (MTSR) United States $8.758B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.238B 29.62
Abivax SA (ABVX) France $8.193B 0.00
Repligen (RGEN) United States $8.039B 86.04
Halozyme Therapeutics (HALO) United States $8.025B 12.83
Jazz Pharmaceuticals (JAZZ) Ireland $7.970B 31.08
Cytokinetics (CYTK) United States $7.355B 0.00
Merus (MRUS) Netherlands $7.223B 0.00
Axsome Therapeutics (AXSM) United States $6.965B 0.00
Nuvalent (NUVL) United States $6.787B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.694B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.438B 0.00
Legend Biotech (LEGN) United States $5.869B 0.00
PTC Therapeutics (PTCT) United States $5.763B 7.83
Krystal Biotech (KRYS) United States $5.739B 29.67
Vaxcyte (PCVX) United States $5.452B 0.00
Alkermes (ALKS) Ireland $5.431B 15.97
Arrowhead Pharmaceuticals (ARWR) United States $5.424B 0.00
TG Therapeutics (TGTX) United States $5.118B 11.60
CRISPR Therapeutics AG (CRSP) Switzerland $5.013B 0.00
Arcellx (ACLX) United States $5.005B 0.00
Protagonist Therapeutics (PTGX) United States $4.973B 128.29
Zealand Pharma (ZLDPF) Denmark $4.769B 4.72
Akero Therapeutics (AKRO) United States $4.323B 0.00
Kymera Therapeutics (KYMR) United States $4.221B 0.00
Praxis Precision Medicines (PRAX) United States $4.207B 0.00
Viking Therapeutics (VKTX) United States $4.156B 0.00
Immunovant (IMVT) United States $4.070B 0.00
Ligand Pharmaceuticals (LGND) United States $3.968B 97.82
ACADIA Pharmaceuticals (ACAD) United States $3.818B 32.24
Belite Bio (BLTE) United States $3.604B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.500B 0.00
ADMA Biologics Inc (ADMA) United States $3.465B 24.61
Telix Pharmaceuticals (TLX) Australia $3.287B 0.00
Celcuity (CELC) United States $3.162B 0.00
CG Oncology (CGON) United States $3.026B 0.00
Arcutis Biotherapeutics (ARQT) United States $2.968B 0.00
Ascentage Pharma Group - (AAPG) China $2.961B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.956B 0.00
Jyong Biotech (MENS) Taiwan $2.955B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.955B 0.00
Disc Medicine (IRON) United States $2.915B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.908B 85.27
Tarsus Pharmaceuticals (TARS) United States $2.897B 0.00
Travere Therapeutics (TVTX) United States $2.894B 0.00
GRAIL (GRAL) United States $2.862B 0.00
Scholar Rock Holding (SRRK) United States $2.783B 0.00
Amicus Therapeutics (FOLD) United States $2.737B 221.75
IDEAYA Biosciences (IDYA) United States $2.651B 0.00
Cidara Therapeutics (CDTX) United States $2.647B 0.00
Viridian Therapeutics (VRDN) United States $2.619B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.608B 0.00
Apogee Therapeutics (APGE) United States $2.523B 0.00
Mineralys Therapeutics (MLYS) United States $2.521B 0.00
Anbio Biotechnology (NNNN) Germany $2.461B 0.00
Zai Lab (ZLAB) China $2.448B 0.00
Apellis Pharmaceuticals (APLS) United States $2.437B 62.13
Agios Pharmaceuticals (AGIO) United States $2.372B 0.00
Bavarian Nordic (BVNRY) Denmark $2.308B 11.16
Liquidia (LQDA) United States $2.270B 0.00
Adaptive Biotechnologies (ADPT) United States $2.258B 0.00
Beam Therapeutics (BEAM) United States $2.254B 0.00
Denali Therapeutics (DNLI) United States $2.203B 0.00
ImmunityBio (IBRX) United States $2.098B 0.00
Arcus Biosciences (RCUS) United States $2.085B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.006B 0.00
Vericel (VCEL) United States $1.969B 162.25
ANI Pharmaceuticals (ANIP) United States $1.962B 15.75
Structure Therapeutics (GPCR) United States $1.892B 0.00
Mesoblast (MESO) Australia $1.874B 0.00
Twist Bioscience (TWST) United States $1.827B 0.00
Edgewise Therapeutics (EWTX) United States $1.817B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.810B 9.88
MannKind (MNKD) United States $1.729B 56.30
Sarepta Therapeutics (SRPT) United States $1.723B 0.00
Alvotech (ALVO) Luxembourg $1.721B 12.98
Immunocore Holdings (IMCR) United Kingdom $1.688B 0.00
Cogent Biosciences (COGT) United States $1.687B 0.00
Nuvation Bio (NUVB) United States $1.622B 0.00
Terns Pharmaceuticals (TERN) United States $1.616B 0.00
Janux Therapeutics (JANX) United States $1.591B 0.00
Sionna Therapeutics (SION) United States $1.549B 0.00
Vera Therapeutics (VERA) United States $1.544B 0.00
UniQure (QURE) Netherlands $1.525B 0.00
Celldex Therapeutics (CLDX) United States $1.521B 0.00
Zenas BioPharma (ZBIO) United States $1.415B 0.00
Certara (CERT) United States $1.393B 25.50
Maze Therapeutics (MAZE) United States $1.375B 0.00
Spyre Therapeutics (SYRE) United States $1.360B 0.00
Trevi Therapeutics (TRVI) United States $1.341B 0.00
Immunome (IMNM) United States $1.327B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.307B 0.00
Stoke Therapeutics (STOK) United States $1.306B 34.12
NeoGenomics (NEO) United States $1.304B 0.00
Dynavax Technologies (DVAX) United States $1.272B 37.35
WAVE Life Sciences (WVE) Singapore $1.251B 0.00
Upstream Bio (UPB) United States $1.241B 0.00
Zymeworks (ZYME) United States $1.237B 0.00
NovoCure (NVCR) Jersey $1.223B 0.00
Novavax (NVAX) United States $1.209B 3.07
Oric Pharmaceuticals (ORIC) United States $1.199B 0.00
Inhibrx Biosciences (INBX) United States $1.169B 0.00
CureVac (CVAC) Germany $1.169B 5.43
AbCellera Biologics (ABCL) Canada $1.168B 0.00
Dianthus Therapeutics (DNTH) United States $1.168B 0.00
Precigen (PGEN) United States $1.162B 0.00
Pharvaris (PHVS) Netherlands $1.129B 0.00
MiMedx (MDXG) United States $1.102B 19.58
Immatics (IMTX) Germany $1.100B 0.00
AnaptysBio (ANAB) United States $1.098B 0.00
Urogen Pharma (URGN) United States $1.088B 0.00
Tango Therapeutics (TNGX) United States $1.059B 0.00
Pharming Group (PHAR) Netherlands $1.057B 0.00
Fortrea Holdings (FTRE) United States $1.040B 22.06
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Intellia Therapeutics (NTLA) United States $1.022B 0.00
Oculis Holding AG (OCS) Switzerland $1.007B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.999B 0.00
Pacira BioSciences (PCRX) United States $0.991B 10.86
Rezolute (RZLT) United States $0.977B 0.00
Sana Biotechnology (SANA) United States $0.973B 0.00
Castle Biosciences (CSTL) United States $0.964B 132.16
BridgeBio Oncology Therapeutics (BBOT) United States $0.962B 0.00
Nanobiotix S.A - (NBTX) France $0.953B 0.00
Nurix Therapeutics (NRIX) United States $0.946B 0.00
BGM Group (BGM) China $0.943B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.943B 0.00
Rapport Therapeutics (RAPP) United States $0.937B 0.00
Kodiak Sciences (KOD) United States $0.931B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.928B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Iovance Biotherapeutics (IOVA) United States $0.913B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.890B 0.00
Biohaven (BHVN) United States $0.874B 0.00
Arbutus Biopharma (ABUS) United States $0.863B 0.00
Palvella Therapeutics (PVLA) United States $0.861B 0.00
MBX Biosciences (MBX) United States $0.859B 0.00
Kura Oncology (KURA) United States $0.858B 0.00
CorMedix Inc (CRMD) United States $0.843B 14.35
Septerna (SEPN) United States $0.825B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.802B 38.47
Bicara Therapeutics (BCAX) United States $0.800B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.790B 0.00
Tyra Biosciences (TYRA) United States $0.764B 0.00
ArriVent BioPharma (AVBP) United States $0.732B 0.00
LENZ Therapeutics (LENZ) United States $0.719B 0.00
Vir Biotechnology (VIR) United States $0.714B 0.00
Astria Therapeutics (ATXS) United States $0.706B 0.00
GH Research (GHRS) Ireland $0.702B 0.00
Gyre Therapeutics (GYRE) United States $0.694B 90.12
MoonLake Immunotherapeutics (MLTX) Switzerland $0.683B 0.00
Arvinas (ARVN) United States $0.683B 0.00
Geron (GERN) United States $0.683B 0.00
MeiraGTx Holdings (MGTX) United States $0.681B 0.00
Replimune (REPL) United States $0.652B 0.00
MapLight Therapeutics (MPLT) $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Erasca (ERAS) United States $0.644B 0.00
Anavex Life Sciences (AVXL) United States $0.626B 0.00
Ventyx Biosciences (VTYX) United States $0.625B 0.00
CytomX Therapeutics (CTMX) United States $0.613B 9.05
Cytek Biosciences (CTKB) United States $0.591B 0.00
Myriad Genetics (MYGN) United States $0.587B 0.00
Compass Therapeutics (CMPX) United States $0.585B 0.00
Opthea (OPT) Australia $0.583B 0.00
Olema Pharmaceuticals (OLMA) United States $0.573B 0.00
Prothena (PRTA) Ireland $0.568B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.568B 0.00
REGENXBIO (RGNX) United States $0.567B 0.00
Inventiva S.A (IVA) France $0.558B 0.00
Gossamer Bio (GOSS) United States $0.546B 0.00
Niagen Bioscience (NAGE) United States $0.546B 42.75
Verastem (VSTM) United States $0.539B 0.00
Emergent Biosolutions (EBS) United States $0.534B 5.13
Ginkgo Bioworks Holdings (DNA) United States $0.530B 0.00
Prime Medicine (PRME) United States $0.513B 0.00
Monopar Therapeutics (MNPR) United States $0.499B 0.00
Absci (ABSI) United States $0.499B 0.00
Keros Therapeutics (KROS) United States $0.494B 10.52
Alumis (ALMS) United States $0.491B 0.00
Rapt Therapeutics (RAPT) United States $0.477B 0.00
DBV Technologies S.A (DBVT) France $0.473B 0.00
NovaBridge Biosciences (NBP) United States $0.461B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.455B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.454B 0.00
Eton Pharmaceuticals (ETON) United States $0.453B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.446B 0.00
Design Therapeutics (DSGN) United States $0.431B 0.00
Cullinan Therapeutics (CGEM) United States $0.425B 0.00
Ocugen (OCGN) United States $0.425B 0.00
PureTech Health (PRTC) United States $0.423B 0.00
Neumora Therapeutics (NMRA) United States $0.415B 0.00
Bright Minds Biosciences (DRUG) United States $0.414B 0.00
Fulcrum Therapeutics (FULC) United States $0.413B 0.00
XOMA Royalty (XOMA) United States $0.401B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.388B 0.00
Kamada (KMDA) Israel $0.383B 19.59
Neurogene (NGNE) United States $0.382B 0.00
Northwest Biotherapeutics (NWBO) United States $0.375B 0.00
Invivyd (IVVD) United States $0.370B 0.00
Tectonic Therapeutic (TECX) United States $0.362B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.354B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.343B 0.00
Benitec Biopharma (BNTC) United States $0.336B 0.00
Aura Biosciences (AURA) United States $0.332B 0.00
AC Immune (ACIU) Switzerland $0.331B 0.00
Amarin (AMRN) Ireland $0.325B 0.00
Contineum Therapeutics (CTNM) United States $0.319B 0.00
Annexon (ANNX) United States $0.316B 0.00
Solid Biosciences (SLDB) United States $0.316B 0.00
Alto Neuroscience (ANRO) United States $0.313B 0.00
EnGene Holdings (ENGN) Canada $0.310B 0.00
DiaMedica Therapeutics (DMAC) United States $0.306B 0.00
Puma Biotechnology (PBYI) United States $0.302B 8.09
Jade Biosciences (JBIO) United States $0.300B 0.00
Immuneering (IMRX) United States $0.286B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.286B 0.00
Kyverna Therapeutics (KYTX) United States $0.285B 0.00
Candel Therapeutics (CADL) United States $0.277B 0.00
Allogene Therapeutics (ALLO) United States $0.265B 0.00
Entrada Therapeutics (TRDA) United States $0.264B 0.00
BioAge Labs (BIOA) United States $0.260B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.260B 0.00
Atea Pharmaceuticals (AVIR) United States $0.260B 0.00
Lifecore Biomedical (LFCR) United States $0.257B 0.00
Alpha Teknova (TKNO) United States $0.252B 0.00
Prima BioMed (IMMP) Australia $0.249B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Sagimet Biosciences (SGMT) United States $0.245B 0.00
Zura Bio (ZURA) United States $0.239B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.237B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.235B 0.00
Voyager Therapeutics (VYGR) United States $0.235B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.234B 0.00
Cabaletta Bio (CABA) United States $0.233B 0.00
Adherex Technologies (FENC) United States $0.224B 0.00
Palisade Bio (PALI) United States $0.223B 0.00
Editas Medicine (EDIT) United States $0.222B 0.00
Black Diamond Therapeutics (BDTX) United States $0.222B 10.81
Aardvark Therapeutics (AARD) United States $0.220B 0.00
Adocia (ADOCY) France $0.216B 0.00
Abeona Therapeutics (ABEO) United States $0.215B 4.57
Orchestra BioMed Holdings (OBIO) United States $0.215B 0.00
Humacyte (HUMA) United States $0.211B 0.00
Tenaya Therapeutics (TNYA) United States $0.209B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.208B 0.00
Genelux (GNLX) United States $0.206B 0.00
Cartesian Therapeutics (RNAC) United States $0.205B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.204B 0.00
SELLAS Life Sciences (SLS) United States $0.199B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.196B 0.00
Caribou Biosciences (CRBU) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.195B 0.00
Molecular Partners AG (MOLN) Switzerland $0.191B 0.00
Nautilus Biotechnology (NAUT) United States $0.191B 0.00
Crescent Biopharma (CBIO) United States $0.182B 0.00
C4 Therapeutics (CCCC) United States $0.167B 0.00
Innate Pharma S.A (IPHA) France $0.164B 0.00
Coherus Oncology (CHRS) United States $0.162B 0.00
Sangamo Therapeutics (SGMO) United States $0.159B 0.00
Nuvectis Pharma (NVCT) United States $0.157B 0.00
MaxCyte (MXCT) United States $0.154B 0.00
Codexis (CDXS) United States $0.153B 0.00
PepGen (PEPG) United States $0.152B 0.00
Forte Biosciences (FBRX) United States $0.150B 0.00
Cognition Therapeutics (CGTX) United States $0.147B 0.00
Cardiff Oncology (CRDF) United States $0.146B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.145B 0.00
Rani Therapeutics Holdings (RANI) United States $0.145B 0.00
Elicio Therapeutics (ELTX) United States $0.145B 0.00
Compugen (CGEN) Israel $0.145B 0.00
Entera Bio (ENTX) Israel $0.143B 0.00
Actuate Therapeutics (ACTU) United States $0.143B 0.00
Scilex Holding (SCLX) United States $0.143B 0.00
Anika Therapeutics (ANIK) United States $0.142B 0.00
Alector (ALEC) United States $0.140B 0.00
Nkarta (NKTX) United States $0.139B 0.00
Spero Therapeutics (SPRO) United States $0.138B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.138B 0.00
Opus Genetics (IRD) United States $0.130B 0.00
TuHURA Biosciences (HURA) United States $0.129B 0.00
Vor Biopharma (VOR) $0.128B 0.00
Seres Therapeutics (MCRB) United States $0.127B 0.00
Agenus (AGEN) United States $0.127B 0.00
Climb Bio (CLYM) United States $0.125B 0.00
Fate Therapeutics (FATE) United States $0.123B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.123B 0.00
VistaGen Therapeutics (VTGN) United States $0.122B 0.00
Applied Therapeutics (APLT) United States $0.122B 0.00
Greenwich LifeSciences (GLSI) United States $0.120B 0.00
Alpha Cognition (ACOG) Canada $0.120B 0.00
Seer (SEER) United States $0.118B 0.00
EXoZymes (EXOZ) United States $0.117B 0.00
BioHarvest Sciences (BHST) Canada $0.117B 0.00
Citius Oncology (CTOR) United States $0.117B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.114B 0.00
Inovio Pharmaceuticals (INO) United States $0.113B 0.00
Turn Therapeutics (TTRX) United States $0.113B 0.00
Estrella Immunopharma (ESLA) United States $0.109B 0.00
Immix Biopharma (IMMX) United States $0.104B 0.00
VTv Therapeutics (VTVT) United States $0.102B 0.00
Oncolytics Biotech (ONCY) Canada $0.102B 0.00
Instil Bio (TIL) United States $0.102B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.099B 0.00
Clene (CLNN) United States $0.099B 0.00
Pliant Therapeutics (PLRX) United States $0.098B 0.00
Tevogen Bio Holdings (TVGN) United States $0.098B 0.00
Whitehawk Therapeutics (WHWK) United States $0.098B 0.00
Biomea Fusion (BMEA) United States $0.097B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.097B 0.00
Coya Therapeutics (COYA) United States $0.096B 0.00
Starpharma Holdings (SPHRY) Australia $0.096B 0.00
Shattuck Labs (STTK) United States $0.095B 0.00
Ovid Therapeutics (OVID) United States $0.094B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.092B 0.00
OKYO Pharma (OKYO) $0.092B 0.00
Adverum Biotechnologies (ADVM) United States $0.091B 0.00
23andMe Holding (MEHCQ) United States $0.090B 0.00
Kalaris Therapeutics (KLRS) United States $0.089B 0.00
Connect Biopharma Holdings (CNTB) United States $0.086B 0.00
CAMP4 Therapeutics (CAMP) United States $0.086B 0.00
Artiva Biotherapeutics (ARTV) United States $0.085B 0.00
Quince Therapeutics (QNCX) United States $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.083B 0.00
InflaRx (IFRX) Germany $0.083B 0.00
Precision BioSciences (DTIL) United States $0.081B 0.00
ATyr Pharma (ATYR) United States $0.080B 0.00
BeyondSpring (BYSI) United States $0.079B 0.00
Fortress Biotech (FBIO) United States $0.078B 0.00
ALX Oncology Holdings (ALXO) United States $0.074B 0.00
Repare Therapeutics (RPTX) Canada $0.073B 0.00
XBiotech (XBIT) United States $0.071B 0.00
Immunic (IMUX) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.071B 0.00
Sutro Biopharma (STRO) United States $0.070B 0.00
Adagene (ADAG) China $0.066B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.066B 0.00
Equillium (EQ) United States $0.065B 0.00
CervoMed (CRVO) United States $0.064B 0.00
Spruce Biosciences (SPRB) United States $0.064B 0.00
BioStem Technologies (BSEM) $0.062B 3.26
TScan Therapeutics (TCRX) United States $0.062B 0.00
MiNK Therapeutics (INKT) United States $0.060B 0.00
Adlai Nortye (ANL) Cayman Islands $0.057B 0.00
Werewolf Therapeutics (HOWL) United States $0.056B 0.00
Cue Biopharma (CUE) United States $0.054B 0.00
Adicet Bio (ACET) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.053B 0.00
Senti Biosciences (SNTI) United States $0.051B 0.00
Annovis Bio (ANVS) United States $0.049B 0.00
Celularity (CELU) United States $0.048B 0.00
Skye Bioscience (SKYE) United States $0.047B 0.00
TELA Bio (TELA) United States $0.046B 0.00
Radiopharm Theranostics - (RADX) Australia $0.046B 0.00
Hyperion DeFi (HYPD) United States $0.045B 0.00
Kezar Life Sciences (KZR) United States $0.044B 0.00
Genenta Science S.p.A (GNTA) Italy $0.044B 0.00
CalciMedica (CALC) United States $0.044B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.043B 0.00
INmune Bio (INMB) United States $0.043B 0.00
PDS Biotechnology (PDSB) United States $0.043B 0.00
Medicus Pharma (MDCX) United States $0.043B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.042B 0.00
X4 Pharmaceuticals (XFOR) United States $0.042B 0.00
Mersana Therapeutics (MRSN) United States $0.042B 0.00
Xilio Therapeutics (XLO) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
BioAtla (BCAB) United States $0.040B 0.00
OnKure Therapeutics (OKUR) United States $0.040B 0.00
Elutia (ELUT) United States $0.038B 0.00
Tvardi Therapeutics (TVRD) United States $0.038B 0.00
Rein Therapeutics (RNTX) United States $0.037B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
RenovoRx (RNXT) United States $0.035B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.034B 0.00
Generation Bio (GBIO) United States $0.034B 0.00
Quantum Biopharma (QNTM) Canada $0.034B 0.00
Femasys (FEMY) United States $0.034B 0.00
Dyadic (DYAI) United States $0.034B 0.00
SAB Biotherapeutics (SABS) United States $0.033B 0.00
ImageneBio (IMA) United States $0.033B 0.00
Tenax Therapeutics (TENX) United States $0.032B 0.00
Tharimmune (THAR) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
BioXcel Therapeutics (BTAI) United States $0.029B 0.00
Synaptogenix (TAOX) United States $0.029B 0.00
Jasper Therapeutics (JSPR) United States $0.029B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
Q32 Bio (QTTB) United States $0.028B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
Pluri (PLUR) Israel $0.027B 0.00
IBio (IBIO) United States $0.027B 0.00
Rallybio (RLYB) United States $0.026B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.025B 0.00
Intensity Therapeutics (INTS) United States $0.025B 0.00
Exicure (XCUR) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.024B 0.00
Moleculin Biotech (MBRX) United States $0.024B 0.00
NextCure (NXTC) United States $0.024B 0.00
Lexaria Bioscience (LEXX) Canada $0.023B 0.00
MetaVia (MTVA) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.020B 0.00
Cingulate (CING) United States $0.020B 0.00
Passage Bio (PASG) United States $0.020B 0.00
Clearside Biomedical (CLSD) United States $0.019B 0.00
Leap Therapeutics (LPTX) United States $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
NewcelX (NCEL) Switzerland $0.018B 0.00
FibroBiologics (FBLG) United States $0.018B 0.00
Lisata Therapeutics (LSTA) United States $0.018B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
Curis (CRIS) United States $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Apollomics (APLM) United States $0.016B 0.00
Longeveron (LGVN) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
Revelation Biosciences (REVB) United States $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
BioCardia (BCDA) United States $0.014B 0.00
Chemomab Therapeutics (CMMB) Israel $0.014B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.013B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Dogwood Therapeutics (DWTX) United States $0.012B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Cocrystal Pharma (COCP) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Purple Biotech (PPBT) Israel $0.011B 0.00
Imunon (IMNN) United States $0.010B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.010B 0.00
Gelteq (GELS) Australia $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
BRIACELL THERAP (BCTX) Canada $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Aprea Therapeutics (APRE) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Bionano Genomics (BNGO) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Black Titan (BTTC) United States $0.004B 0.00
Psyence Biomedical (PBM) Canada $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Alps Group (ALPS) United States $0.003B 2.21
GT Biopharma (GTBP) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00